Stocks
Atara Biotherapeutics (ATRA) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 3 769% | 5 421% | 2 665% | 6 500% | 17 920% | 20 938% | |||
| Changes by years, y/y, % | +3 303pp | +1 652pp | -2 756pp | +3 834pp | +11 421pp | +107.5% | |||
Atara Biotherapeutics. R&D/CAPEX, %
Atara Biotherapeutics. R&D/CAPEX, changes, pp
Atara Biotherapeutics (ATRA) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 15 578% | 11 251% | 20 245% | 99 957% | 33 159% | 20 938% | ||
| Changes by years, y/y, % | +12 700pp | +6 677pp | -32 904pp | -69 003pp | +17 581pp | |||
| Changes by quarters, q/q, % | -153 382pp | -4 327pp | +8 994pp | +79 712pp | -66 798pp | |||
